We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WT
326
Whittier Trust
California
$60K +$55.2K +750 New
OMCS
327
Old Mutual Customised Solutions
South Africa
$56K +$51.5K +700 New
US Bancorp
328
US Bancorp
Minnesota
$53K +$48.8K +663 New
GT
329
Glenmede Trust
Pennsylvania
$53K +$49.6K +674 New
Envestnet Asset Management
330
Envestnet Asset Management
Illinois
$48K +$43.7K +594 New
KTC
331
Kistler-Tiffany Companies
Pennsylvania
$48K +$44.2K +600 New
MAM
332
Mizuho Asset Management
Japan
$47K +$43.3K +588 New
CCM
333
Cazenove Capital Management
United Kingdom
$45.6K +$42K +570 New
STC
334
SEI Trust Company
Pennsylvania
$45K +$41.6K +565 New
RNS
335
Robert N. Shapiro
$40K +$36.7K +498 New
FCT
336
Family Capital Trust
Massachusetts
$38K +$35.3K +480 New
HNB
337
Huntington National Bank
Ohio
$37K +$33.7K +457 New
EWM
338
Evercore Wealth Management
New York
$36K +$33.5K +455 New
Thrivent Financial for Lutherans
339
Thrivent Financial for Lutherans
Minnesota
$32.4K +$29.8M +404,820 New
FNBT
340
FineMark National Bank & Trust
Florida
$32K +$29.8K +404 New
LWCFA
341
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$24K +$22.1K +300 New
PP
342
Palladium Partners
Virginia
$24K +$22.1K +300 New
SFPIA
343
Stevens First Principles Investment Advisors
California
$24K +$22.1K +300 New
WTC
344
WhitTier Trust Company
Nevada
$23K +$21K +285 New
HR
345
Howe & Rusling
New York
$20K +$18.2K +247 New
SO
346
STRS Ohio
Ohio
$17K +$15.3K +208 New
SFSIG
347
San Francisco Sentry Investment Group
California
$17K +$15.7K +213 New
DBT
348
Dubuque Bank & Trust
Iowa
$16K +$15.1K +205 New
ST
349
Stifel Trust
Missouri
$13K +$11.7K +159 New
FBT
350
Founders Bank & Trust
Michigan
$13K +$11.8K +160 New
12 13
14
15 16

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.